Clinical trial news for a geographic atrophy treatment candidate topped retina news in September, with studies regarding age-related macular degeneration also making headlines.
Here are the top five most read retina articles of the month on Healio.com/OSN:
1. Lampalizumab trial for geographic atrophy fails to meet endpoint
A phase 3 study of lampalizumab for geographic atrophy failed to meet its primary endpoint of reducing mean change in lesion area, Roche announced. Read more.
2. Treat-and-extend comparable to monthly injections in AMD
A multicenter 12-month phase 3b study showed that
Uncategorized